Articles by Daniel Marsh
Soleno Halts European Drug Review Following $2.9B Neurocrine Acquisition
Soleno Therapeutics has withdrawn its European marketing application for VIOKAT, a day after agreeing to a $2.9 billion all-cash acquisition by Neurocrine Biosciences. The move halts a regulatory review previously expected to conclude by mid-2026.
Indian Equities Climb on IT Rally Ahead of RBI Policy, Earnings
Indian benchmarks advanced Tuesday, with the Nifty 50 closing above 23,100, driven by a rally in IT stocks ahead of quarterly earnings and the RBI's policy decision.
Enovix Surges 12% Amid Analyst Shifts; Indian Markets Slump on Oil Spike
Enovix shares rallied nearly 12% on Monday despite below-average volume and divergent analyst views. Meanwhile, Indian equity indices tumbled over 800 points as Brent crude surged past $111, stoking inflation fears.
Neurocrine Acquires Soleno in $2.9B Deal for Rare Disease Drug Vykat XR
Neurocrine Biosciences will purchase Soleno Therapeutics in a $2.9 billion all-cash transaction, securing the commercial rights to Vykat XR. The deal offers $53 per share to Soleno stockholders.
Amazon Imposes 3.5% Fuel Surcharge on Sellers Amid Rising Oil Prices
Amazon is introducing a 3.5% fuel and logistics surcharge on fulfillment fees for third-party sellers in the U.S. and Canada, effective April 17. The move comes as Brent crude oil prices hover around $110 per barrel, increasing delivery costs across the logistics sector.
Mortgage Rates Inch Lower, Affordability Squeeze Persists for Spring Buyers
U.S. mortgage rates edged down slightly, with the 30-year fixed average at 6.43%. However, purchase applications declined and the median monthly payment rose, highlighting ongoing affordability challenges.
Dow Gains on Ceasefire Hopes, But Oil and Fed Fears Linger
The Dow Jones Industrial Average advanced 0.18% to 46,587.48 by midday Monday, buoyed by optimism over potential Iran ceasefire negotiations. However, caution prevailed as oil prices remained elevated and expectations for Federal Reserve easing diminished.
Stocks Edge Higher on Geopolitical Hopes Amid Inflation, Rate Cut Concerns
Major U.S. stock indices rose Monday, buoyed by reports of renewed Iran ceasefire talks, though gains were tempered by persistent inflation worries and shifting expectations for Federal Reserve rate cuts.
JPMorgan Price Target Cut by Evercore Amid CEO's Geopolitical Warning
Evercore ISI reduced its JPMorgan Chase price target to $320 from $350, as shares traded near $296. CEO Jamie Dimon cautioned that war in Iran could trigger oil shocks and persistent inflation.
Major Investors Reduce Pfizer Holdings Amid Growth Transition
Three institutional investors trimmed their Pfizer positions by a combined 740,174 shares in the fourth quarter, filings show, as the pharmaceutical giant navigates its post-pandemic transition.